Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot study

Highlights • 150 patients: randomised to phenytoin (50), valproate (50) and levetiracetam (50). • Phenytoin group: seizures were controlled in 68% with lorazepam + phenytoin. • Valproate group: seizures were controlled in 68% with lorazepam + valproate. • Levetiracetam group: seizures were controlle...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epilepsy research 2015-08, Vol.114, p.52-58
Hauptverfasser: Mundlamuri, R.C, Sinha, S, Subbakrishna, D.K, Prathyusha, P.V, Nagappa, M, Bindu, P.S, Taly, A.B, Umamaheswara Rao, G.S, Satishchandra, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • 150 patients: randomised to phenytoin (50), valproate (50) and levetiracetam (50). • Phenytoin group: seizures were controlled in 68% with lorazepam + phenytoin. • Valproate group: seizures were controlled in 68% with lorazepam + valproate. • Levetiracetam group: seizures were controlled in 78% with lorazepam + levetiracetam. • Phenytoin, valproate, and levetiracetam are safe and equally efficacious.
ISSN:0920-1211
1872-6844
DOI:10.1016/j.eplepsyres.2015.04.013